75 results
Page 3 of 4
8-K
EX-99.1
a8y1u
7 Dec 20
Risks Related to Our Business and the Development and Commercialization of Our Product Candidates
4:58pm
PRE 14A
o2krkr0g m1rycbi
23 Jun 20
Preliminary proxy
5:05pm
8-K
EX-3.1
ixonnzrtc64 pti2w
12 Jun 20
Amendments to Articles of Incorporation or Bylaws
5:11pm
DEF 14A
qdi1l20wtxl7hzf7eyjl
21 Apr 20
Definitive proxy
5:26pm
10-K
47gptgesmz
26 Mar 20
Annual report
4:01pm
10-Q
d3pnaryo
7 Nov 19
Quarterly report
4:55pm
8-K
EX-3.2
p5t5ya3eoz3u2zlv2 9s
20 Sep 19
IGM Biosciences Announces Closing of Initial Public Offering, Including Full
5:27pm
424B4
as68mvprlnirtlq0cocj
18 Sep 19
Prospectus supplement with pricing info
4:43pm
S-1/A
EX-1.1
6nsk35reaxxvl1qlj
3 Sep 19
IPO registration (amended)
6:08am
S-1/A
EX-10.3
g2dwq882hyc
3 Sep 19
IPO registration (amended)
6:08am
S-1/A
EX-3.4
ccjl6qnzr39x3t8 t48
3 Sep 19
IPO registration (amended)
6:08am
S-1/A
eldnn8gg05lmj6
3 Sep 19
IPO registration (amended)
6:08am
S-1
EX-10.14
3ng3ndlujp0te94nz07k
19 Aug 19
IPO registration
5:25pm
S-1
EX-10.17
3uuoaug
19 Aug 19
IPO registration
5:25pm